2009). Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2alpha) dephosphorylation in mammalian development.
The study of neonatal immunology has been hampered by lack of access to infant samples. Novel sample sparing methods and systems-wide approaches have uniquely expanded this field, demonstrating that newborn immunity varies widely but converges over the first 3 months of life. During this important time window, environmental and genetic factors impact the infant immune system and can influence lifelong immunity.
After being protected for months while developing in utero, the first days, weeks, and months of neonatal life are among the harshest immunologically. While variability in the human immune response has been shown in adults (Brodin et al., 2015) , the neonatal immune system has long been considered a uniform ''clean slate.'' However, in this issue of Cell, recent evidence from Olin et al. (2018) suggests wildly variable immune profiles among neonates, possibly attributed to differences in in utero conditioning, modes of delivery, environmental factors, and transferred maternal antibodies (Dauby et al., 2012; MacGillivray and Kollmann, 2014) . Despite these differences, many features of the neonatal immune response across all infants remain immature and must work in ''overdrive'' to protect the fragile child from infectious assaults. Increasing data now show that early infections, maternal antibodies, microbial colonization, etc. over the first weeks/months of life drastically alter neonatal immunity and have long-term consequences on disease susceptibility (Laforest-Lapointe and Arrieta, 2017; de Bree et al., 2018) . Thus, understanding the nature of the first neonatal immune interactions with the world may provide critical clues for saving newborn lives and for reshaping lifelong health (Figure 1) . However, studies aimed at profiling the evolution of early immunity have been limited by the lack of access to longitudinal specimens from infants.
Although neonates possess all the components of the cellular immune response, significant defects in T and B cell signaling, reduced and anergized innate immune cells, compromised cellular extravasation, Th2-inflmmatory biases, and delayed generation of antibodies collectively hinder the immune response upon infection. Thus, a large proportion of infant deaths from infectious diseases occur in the first month of life (Whittaker et al., 2018) . Variably transferred maternal antibodies provide a critical exogenously acquired early barrier to infection but have been implicated in dampening responses to vaccination and prevent effective neonatal vaccination (Edwards, 2015) . Therefore, the first few days/weeks of life represent a window of extreme vulnerability and a virtual immune ''black box'' due to our limited understanding of the active antipathogen immune functions, the mechanisms of antibody transfer, and the influence of early infections on lifelong health. The application of systems-level omics tools has revolutionized our understanding of the adult human immune response to vaccination, infection, and disease (Hagan et al., 2015; Davis et al., 2017) . The agnostic application of emerging hypothesis-independent big-data tools have consistently reshaped our understanding of human immunity. However, due to limited infant sampling, the application of these tools has been slower in dissecting neonatal immunology; however, these tools hold tremendous promise for unlocking the mysteries of the neonatal immune system.
In their recent paper, Olin et al. employed several systems-level analyses to begin dissecting the longitudinal development of the neonatal immune system. The authors applied sample sparing analytics to capture the widest possible proteomics, cellul-omics, microbiome-omics, and transcriptomic data, analyzing hundreds of chemokines, plasma proteins, and cell populations from 100 mL of blood. 100 neonates, including full-term and preterm births, were analyzed longitudinally over 6 months and compared to their parents. Olin et al. used topological data analysis to integrate cell frequencies, protein concentrations, and clinical metadata to holistically understand neonatal immune profiles and their evolution over 6 months. Strikingly, there were dramatic changes in cellular frequencies, transcriptional profiles, and microbial communities between babies. However, immune development followed a singular stereotypical pattern thereafter, with preterm and term profiles converging at approximately 3 months, driven heavily by the converging normalization of neutrophil and naive CD4+ T cells frequencies.
Olin et al. hypothesized that the first 3 months represent a critical but unappreciated window of immunological pressures where environmental factors shape immune system variation. However, following this window of variation, neonatal responses converged and developed to mimic those of their parents, implying some level of imprinting across both the adaptive and innate systems. Whether imprinting relates to in utero education or familial-microbial colonization remains to be determined. However, Olin et al. saw dynamic cytokine levels over the first month and increased dysbiosis among preterm infants, suggesting that the stereotypic development trajectory may be directly perturbed by microbiome dysregulation. This offers an opportune and druggable target to shape developing immunity in neonates.
Olin et al. fill a critical gap in our knowledge by dissecting longitudinal immune development, revealing immunologic variability at birth and providing the first insights into factors contributing to this variability. The first months of life represent an immense immunological challenge, exacerbated by the inability to receive vaccines. Given the striking functional and phenotypic differences in neonatal and adult immunity (Brodin and Davis, 2017) , a one-size-fits-all vaccine or therapeutic intervention designed for adults may have limited efficacy in neonates. Thus, there is an urgent need to develop a deeper comprehensive understanding of infant immunity, to delineate immune barriers to early vaccination, to develop customized therapeutic interventions that selectively augment immunity in infants, and to ultimately define novel approaches that push the system toward diseasefree longevity.
Sample sparing methods that are able to capture the greatest amount of immunological, biochemical, and genomic data from infants over time will be critical for comprehensive cataloging of the infant immune landscape. While the field of neonatal immunology has relied on cord blood as a proxy, Olin et al. also showed that cord blood is phenotypically distinct from circulating blood in neonates. Thus, immune profiling of many biological samples, including mother's blood, baby's blood, saliva, mucus, urine, and fecal material, have the potential to further revolutionize our understanding of infant immunity.
While originally thought to be uniform, mounting data strongly argue that neonatal immunity varies wildly (Dauby et al., 2012; MacGillivray and Kollmann, 2014) . Ultimately, while the study described by Olin et al. answers a number of questions about the earliest development of infant immunity, it also prompts many further questions. Defining the fundamental underlying mechanisms that drive dramatic shifts in preterm infant immunity, discovering Neonates show significant immune variation at birth, converging at approximately 3 months along a stereotypical path. However, early life impacts, both environmental and genetic, such as gestational age, mode of delivery, length of hospital stay, nutrition of mother and newborn, exposure to infectious agents, microbiome colonization, and antibiotic use are thought to influence lifelong health, playing roles in determining vaccine immunity, the presence of allergies, and the development of diabetes and autoimmune diseases, as well as modulating overall disease susceptibility and longevity. Olin et al. show the unique nature of the first 3 months of life, a previously unappreciated period of great flux that may shape the immune system for the child's entire life.
the immunological switch that stereotypically synchronizes immunity, delineating the factors that shape microbial colonization, and most critically, identifying how early immune profiles drive lifelong immunity are all certain to reshape infant care. Thus, Olin et al. provide us with a first glimpse at an infinite landscape of opportunity for the rational design of next-generation approaches to improve health in our most vulnerable and precious population.
